By Tara Rippin • Published: 14 Sep 2020 • 14:24
Spain’s first trials of a coronavirus vaccine developed by US firm Johnson & Johnson are scheduled to begin today (September 14).
THREE hospitals are carrying out the clinical trials – the Marques de Valdecilla Hospital in Santander and La Paz and La Princesa university hospitals in Madrid.
The first phase of the tests took place in the US and Belgium, with Spain joining Belgium and Germany for the second phase.
Some 190 volunteers are expected to take part, with 75 adults from La Paz, the hospital’s head of the clinical trials, Alberto Borobia told Spanish news agency, Servimedia.
Fifty of these participants will be aged 18 to 55 with 25 aged over 65.
He explained they will each receive either one shot of the vaccine or two shots a month apart.
Some volunteers will be given a placebo, and doctors will monitor all of those taking part throughout the trials.
It is hoped the first round of vaccination will be completed by the end of September.
According to Borobia, though the final results are expected no sooner than in 16 months, the move to phase three was given the go ahead upon “satisfactory preliminary results.”
World Health Organisation (WHO) stipulates that a potential vaccine must complete three phases of clinical trials to be approved for mass production.
The first phase is is on a smaller scale with around 100 volunteers to determine safety and clinical tolerance.
Phase two is on a larger scale, with up to 1,000 participants of different ages, ethnicity and other factors. Dose levels and intervals are also determined during this stage.
As the trials move to phase three, up to 10,000 volunteers can be involved, with the maximum representation of target population categories.
Definitive evidence of safety and the capacity to produce the desired result or effect is necessary before a candidate vaccine can move into industrial production.
The pandemic is on the rise in both Spain and in the UK with both countries having reported over the last few days the highest number of positive cases since March.
Share this story
Subscribe to our Euro Weekly News alerts to get the latest stories into your inbox!
By signing up, you will create a Euro Weekly News account if you don't already have one. Review our Privacy Policy for more information about our privacy practices.
Tara Rippin is a reporter for Spain’s largest English-speaking newspaper, Euro Weekly News, and is responsible for the Costa Blanca region. She has been in journalism for more than 20 years, having worked for local newspapers in the Midlands, UK, before relocating to Spain in 1990. Since arriving, the mother-of-one has made her home on the Costa Blanca, while spending 18 months at the EWN head office in Fuengirola on the Costa del Sol. She loves being part of a community that has a wonderful expat and Spanish mix, and strives to bring the latest and most relevant news to EWN’s loyal and valued readers.
Share your story with us by emailing newsdesk@euroweeklynews.com, by calling +34 951 38 61 61 or by messaging our Facebook page www.facebook.com/EuroWeeklyNews
a vaccine for what? for nothing it’s just big business for the pharmaceutical industry and it’s paid for with our tax money Politicians steal this money from us to secure the profits of your friends so that they “earn” big money after the politicians get a wellpaid job at them
Comments are closed.
By signing up, you will create a Euro Weekly News account if you don’t already have one. Review our Privacy Policy for more information about our privacy practices.
Download our media pack in either English or Spanish.